Sym SJ - Search Results

1

Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07.

Kim ST, Kim SY, Lee J, Yun SH, Kim HC, Lee WY, Kim TW, Hong YS, Lim SB, Baek JY, Oh JH, Ahn JB, Shin SJ, Han SW, Kim SG, Kang SY, Sym SJ, Zang DY, Kim YH, Choi IS, Kang JH, Kim MJ, Park YS. Kim ST, et al. Among authors: sym sj. J Clin Oncol. 2022 Nov 20;40(33):3868-3877. doi: 10.1200/JCO.21.02962. Epub 2022 Jun 30. J Clin Oncol. 2022. PMID: 35772045 Free PMC article. Clinical Trial.

2

A Phase II study of cetuximab (Erbitux) plus FOLFIRI for irinotecan and oxaliplatin-refractory metastatic colorectal cancer.

Koo DH, Lee JL, Kim TW, Chang HM, Ryu MH, Lee SS, Kim MK, Sym SJ, Lee JS, Kang YK. Koo DH, et al. Among authors: sym sj. J Korean Med Sci. 2007 Sep;22 Suppl(Suppl):S98-S103. doi: 10.3346/jkms.2007.22.S.S98. J Korean Med Sci. 2007. PMID: 17923763 Free PMC article. Clinical Trial.

3

Docetaxel monotherapy as a second-line treatment after failure of fluoropyrimidine and platinum in advanced gastric cancer: experience of 154 patients with prognostic factor analysis.

Jo JC, Lee JL, Ryu MH, Sym SJ, Lee SS, Chang HM, Kim TW, Lee JS, Kang YK. Jo JC, et al. Among authors: sym sj. Jpn J Clin Oncol. 2007 Dec;37(12):936-41. doi: 10.1093/jjco/hym123. Jpn J Clin Oncol. 2007. PMID: 18211985

4

Salvage chemotherapy with biweekly irinotecan, plus 5-fluorouracil and leucovorin in patients with advanced gastric cancer previously treated with fluoropyrimidine, platinum, and taxane.

Sym SJ, Ryu MH, Lee JL, Chang HM, Kim TW, Lee SS, Lee JS, Kang YK. Sym SJ, et al. Am J Clin Oncol. 2008 Apr;31(2):151-6. doi: 10.1097/COC.0b013e31815878a2. Am J Clin Oncol. 2008. PMID: 18391599

5

Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs).

Sym SJ, Ryu MH, Lee JL, Chang HM, Kim TW, Kim HC, Kim KH, Yook JH, Kim BS, Kang YK. Sym SJ, et al. J Surg Oncol. 2008 Jul 1;98(1):27-33. doi: 10.1002/jso.21065. J Surg Oncol. 2008. PMID: 18452195 Clinical Trial.

6

Dose escalation of imatinib after failure of standard dose in Korean patients with metastatic or unresectable gastrointestinal stromal tumor.

Park I, Ryu MH, Sym SJ, Lee SS, Jang G, Kim TW, Chang HM, Lee JL, Lee H, Kang YK. Park I, et al. Among authors: sym sj. Jpn J Clin Oncol. 2009 Feb;39(2):105-10. doi: 10.1093/jjco/hyn134. Epub 2008 Dec 3. Jpn J Clin Oncol. 2009. PMID: 19052040

7

Kinase mutations and efficacy of imatinib in Korean patients with advanced gastrointestinal stromal tumors.

Kim TW, Ryu MH, Lee H, Sym SJ, Lee JL, Chang HM, Park YS, Lee KH, Kang WK, Shin DB, Bang YJ, Lee JS, Kang YK. Kim TW, et al. Among authors: sym sj. Oncologist. 2009 May;14(5):540-7. doi: 10.1634/theoncologist.2008-0145. Epub 2009 May 2. Oncologist. 2009. PMID: 19411681 Free article.

8

Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer.

Sym SJ, Ryu MH, Kang HJ, Lee SS, Chang HM, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Kang YK. Sym SJ, et al. Cancer Chemother Pharmacol. 2010 Jul;66(2):373-80. doi: 10.1007/s00280-009-1171-x. Epub 2009 Nov 21. Cancer Chemother Pharmacol. 2010. PMID: 19936751 Clinical Trial.

9

Neoadjuvant docetaxel, capecitabine and cisplatin (DXP) in patients with unresectable locally advanced or metastatic gastric cancer.

Sym SJ, Chang HM, Ryu MH, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Kang YK. Sym SJ, et al. Ann Surg Oncol. 2010 Apr;17(4):1024-32. doi: 10.1245/s10434-009-0838-1. Epub 2009 Nov 26. Ann Surg Oncol. 2010. PMID: 19941081 Clinical Trial.

10

A UGT1A1*28 and *6 genotype-directed phase I dose-escalation trial of irinotecan with fixed-dose capecitabine in Korean patients with metastatic colorectal cancer.

Kim KP, Kim HS, Sym SJ, Bae KS, Hong YS, Chang HM, Lee JL, Kang YK, Lee JS, Shin JG, Kim TW. Kim KP, et al. Among authors: sym sj. Cancer Chemother Pharmacol. 2013 Jun;71(6):1609-17. doi: 10.1007/s00280-013-2161-6. Epub 2013 Apr 18. Cancer Chemother Pharmacol. 2013. PMID: 23595344 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page